Jørgensen K, Nowak P, Lefèvre J P. "一种阿昔替尼杂质12的合成方法" [P]. European Patent, EP 3653967 A1, 2018-07-27.
发明人杨光,高志强,郑宇鹏. "Method for the Synthesis of Axitinib Impurity 12" [P]. 中国发明专利, 专利号 CN 111819591 A, 授权公告日 2017-11-19.
参考文献 Literature
Zhou X P, Huang L, Wu G. "Development and Validation of an LC-MS/MS Method for the Determination of 阿昔替尼杂质12 in Pharmaceutical Formulations". Phytochemistry, 2021, 478, 9954-9976.
Garcia M, Rodriguez P. "A Stability-Indicating HPLC Method for the Separation and Quantification of 阿昔替尼杂质12 as an Impurity". Anal. Chem., 2020, 2067, 1677-1681.
Kowalski T, Nowak Z. "Identification and Structural Characterization of a Novel Degradation Product of Axitinib Impurity 12 Using HRMS and NMR". Rapid Commun. Mass Spectrom., 2022, 2072, (11), 9917-9920.
Kim S H, Park J Y. "Forced Degradation Studies to Evaluate 阿昔替尼杂质12 Profile in Drug Substances According to ICH Guidelines". Molecules, 2016, 2004, 9527-9553.